National Test Launch Drives Steep Growth in Atossa's Q1 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) – Atossa Genetics today said that its revenues in the first quarter increased more than three-fold, driven by the national launch of its breast cancer diagnostic test.

The Seattle-based firm recorded $182,670 in revenues, compared to $54,713 in the first quarter of 2012. Diagnostic testing service revenues were up 221 percent to $169,230 from $52,713 a year ago, while product sales rose more than six-fold to $13,440 from $2,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.